Tulane University. (2025, April 22). Pulmonary fibrosis has no cure: Could a cancer drug hold the answer?. ScienceDaily. Retrieved May 7, 2025 from www.sciencedaily.com / releases / 2025 / 04 ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

Credit: Explode / Shutterstock. The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD) prevalence, an ageing ...

A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors. A ...

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than ...

April 15, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid stent system has received premarket approval from the FDA for ...

First Dual-Layer Micromesh Carotid Stent Approved for Use in the U.S. ALISO VIEJO, Calif., April 15, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned ...

Study data support the application of remote ambulatory pulmonary artery pressure measurement using an implantable hemodynamic monitor to assess prognosis at baseline and as a function of change over ...

LAHORE: A shocking revelation has emerged from the Punjab Institute of Cardiology (PIC), where expired cardiac stents were inserted into patients at PIC, ARY News reported citing Auditor General ...